Anti-FcεRIα autoantibodies in autoimmune-mediated disorders -: Identification of a structure-function relationship

被引:219
作者
Fiebiger, E
Hammerschmid, F
Stingl, G
Maurer, D
机构
[1] Univ Vienna, Sch Med, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria
[2] Novartis Res Inst, A-1235 Vienna, Austria
关键词
autoimmunity; IgE receptors; histamine release; complement activation; chronic urticaria;
D O I
10.1172/JCI511
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Anti-Fc epsilon RI alpha autoantibodies (autoAbs) occur and may be of pathogenetic relevance in a subset of chronic urticaria (CU) patients. To analyze the prevalence and magnitude of the humoral anti-Fc epsilon RI alpha response in cohorts of CU patients compared with individuals suffering from classic skin-related (auto)immune diseases, we developed an ELISA system for the measurement of anti-Fc epsilon RI alpha: autoAbs in non-fractionated serum samples, Results obtained using this assay correlated well with those generated by Western-blotting, We found IgG anti-Fc epsilon RI alpha autoreactivity in 38% of CU patients but not in atopic dermatitis patients, psoriatics, or healthy individuals, We frequently detected anti-Fc epsilon RI alpha autoAbs in pemphigus vulgaris (PV, 39%), dermatomyositis (DM, 36%), systemic lupus erythematosus (SLE, 20%), and bullous pemphigoid (BP, 13%), While the autoAb titers in DM, SLE, BP, and PV were similar to those encountered in CU patients, only anti-Fc epsilon RI alpha CU serum specimens displayed pronounced histamine-releasing activity. The anti-Fc epsilon RI alpha: autoAbs in CU patients belong predominantly to the complement-fixing subtypes IgG1 and IgG3, whereas in DM, PV, and BP, they were found to be mainly of the IgG2 or IgG4 subtype, Complement-activating properties of antiF epsilon RI alpha autoAbs can indeed be of pathogenetic relevance, because C5a receptor blockade on basophils as well as de-complementation reduced drastically the histamine-releasing capacity of most anti-Fc epsilon RI alpha-reactive CU sera, As a consequence, therapeutic efforts in CU should aim at altering not only the quantity but also the complement-activating properties of IgG anti-Fc epsilon RI alpha autoAbs.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 34 条
[1]   REGULATION OF CYTOKINE PRODUCTION BY SOLUBLE CD23 - COSTIMULATION OF INTERFERON-GAMMA SECRETION AND TRIGGERING OF TUMOR-NECROSIS-FACTOR-ALPHA RELEASE [J].
ARMANT, M ;
ISHIHARA, H ;
RUBIO, M ;
DELESPESSE, G ;
SARFATI, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1005-1011
[2]   DETECTION AND QUANTIFICATION OF SECRETED SOLUBLE FC-GAMMA-RIIA IN HUMAN SERA BY AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
ASTIER, A ;
DELASALLE, H ;
MONCUIT, J ;
FREUND, M ;
CAZENAVE, JP ;
FRIDMAN, WH ;
HANAU, D ;
TEILLAUD, JL .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 166 (01) :1-10
[3]   Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls [J].
Bischoff, SC ;
Schwengberg, S ;
Wordelmann, K ;
Weimann, A ;
Raab, R ;
Manns, MP .
GUT, 1996, 38 (01) :104-114
[4]  
BOROS P, 1994, J IMMUNOL, V152, P302
[5]   THE DEGRADATION PRODUCT OF THE C5A ANAPHYLATOXIN C5A(DESARG) RETAINS BASOPHIL-ACTIVATING PROPERTIES [J].
BURGI, B ;
BRUNNER, T ;
DAHINDEN, CA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) :1583-1589
[6]   MECHANISM AND REGULATION OF IMMUNOGLOBULIN ISOTYPE SWITCHING [J].
COFFMAN, RL ;
LEBMAN, DA ;
ROTHMAN, P .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :229-270
[7]   Serum IgG autoantibodies directed against the a chain of Fc epsilon RI: A selective marker and pathogenetic factor for a distinct subset of chronic UrtiCaria patients? [J].
Fiebiger, E ;
Maurer, D ;
Holub, H ;
Reininger, B ;
Hartmann, G ;
Woisetschlager, M ;
Kinet, JP ;
Stingl, G .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2606-2612
[8]   Anti-IgE and anti-Fc epsilon RI autoantibodies in clinical allergy [J].
Fiebiger, E ;
Stingl, G ;
Maurer, D .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (06) :784-789
[9]  
FUREDER W, 1995, J IMMUNOL, V155, P3152
[10]  
GAVIN AL, 1995, IMMUNOLOGY, V86, P392